As you all know, I have high hopes for the genetic profiling company 23andMe. Although 23andMe has not officially launched a product available to the public, it turns out that the founders have chosen a great name for their company.
Nancy Friedman, a name developer and corporate copywriter based in Oakland, has written a lengthy analysis of the name â€˜23andMeâ€™ on her blog â€˜Away with Words.â€™ She suggests that the name was deftly crafted and is even better than the oft-suggested name â€˜46andMe.â€™ Ms. Friedmanâ€™s post is also the first place Iâ€™ve ever seen a pronunciation for Anne Wojcickiâ€™s last name (which is wo-JIT-skee). Turns out I wasnâ€™t too far off!
Thanks for the link and the kind words! One correction to what was probably a typo: the alternative I suggested was “46andMe” (the actual number of chromosomes), not “43andMe.”
I thought it was a great post! Thanks for the typo correction, not sure how I missed that one!
There are two drawbacks to the name 23andme:
1.) It may limit the company to human genetics. This is OK; however, if the company has a Google like ambition to organize all genetic knowledge, it should have a different name.
2.) Within humans, the name is exclusionary since it does not take into account conditions such as Klinefelter’s syndrome (esp. xxyy). In other words, 23 could be a rather simplistic view of a “me”.
Is this a publicly tradeb stock? Thanks.
Comments are closed.